Financials

  • Market Capitalization 5.61 B
  • Employee 433
  • Founded 2018
  • CEO N/A
  • Website www.mirumpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00MH7T2M7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-168.06
Rapporto prezzo/fatturato
7.61

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1162
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
306.68 USD+1.61%-0.40%+7.63%+63.89%6.11 B USD
1177
IMVT
Immunovant, Inc. - Common Stock
28.94 USD-5.02%-13.53%-22.31%+50.65%5.98 B USD
1246
ERAS
Erasca, Inc. - Common Stock
15.55 USD-2.99%+6.65%-2.63%+542.56%5.44 B USD
1267
PTCT
PTC Therapeutics, Inc. - Common Stock
63.24 USD-2.26%-1.19%-5.61%-4.83%5.28 B USD

Notizie